Evidence map›Paper›PMID 27129214›Full record

ArticleThe Journal of biological chemistry2016

Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT).

Brian A Lewis, Alma L Burlingame, Samuel A Myers

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. NSUN7-mediated mJournal of translational medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. HumanResearch square · 2025
    Article
  8. Article
  9. Cancers · 2024
    Review
  10. O-GlcNAcylation mediates HActa pharmacologica Sinica · 2024
    Article
  11. Article
  12. Article
  13. MYC: a complex problem.Trends in cell biology · 2023
    Review
  14. Nutrient sensitive proteinLife science alliance · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Brian A LewisTranscriptional Regulation and Biochemistry Unit, Metabolism Branch, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892. Electronic address: lewisbri@mail.nih.gov.
Alma L BurlingameDepartment of Pharmaceutical Chemistry, University of California, San Francisco, California 94158.
Samuel A MyersDepartment of Pharmaceutical Chemistry, University of California, San Francisco, California 94158.
University of California, San Francisco · USNational Institutes of Health · US

Funding

Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Regulation of Transcription Initiation and Elongation by O-GlcNAcylation EnzymesZIABC011223 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEWIS, BRIAN · 2009 to 2016
$3.8M
NIGMS NIH HHS P41 GM103481
6 · The paper itself

Abstract

Although the O-linked N-acetylglucosamine (O-GlcNAc) modification of the RNA polymerase II C-terminal domain was described 20 years ago, the function of this RNA polymerase II (pol II) species is not known. We show here that an O-GlcNAcylated pol II species (pol IIγ) exists on promoters in vitro Inhibition of O-GlcNAc-transferase activity and O-GlcNAcylation prevents pol II entry into the promoter, and O-GlcNAc removal from pol II is an ATP-dependent step during initiation. These data indicate that O-GlcNAc-transferase activity is essential for RNA pol II promoter recruitment and that pol II goes through a cycling of O-GlcNAcylation at the promoter. Mass spectrometry shows that serine residues 2 and 5 of the pol II C-terminal domain are O-GlcNAcylated, suggesting an overlap with the transcription factor IIH (TFIIH)-dependent serine 5 phosphorylation events during initiation and P-TEFb (positive transcriptional elongation factor b) events during elongation. These data provide unexpected and important insights into the role of a previously ill-defined species of RNA polymerase II in regulating transcription.

Indexed as

Promoter Regions, GeneticHumansIn Vitro TechniquesN-AcetylglucosaminyltransferasesRNA Polymerase IIN-AcetylglucosaminyltransferasesRNA Polymerase IIgene regulationO-GlcNAcylationO-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT)RNA polymerase IItranscription

Identifiers

PMID27129214
PMCPMC4933165
OpenAlexW2342386520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.